Target Price | CHF13.99 |
Price | CHF11.03 |
Potential |
26.87%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Clariant 2026 .
The average Clariant target price is CHF13.99.
This is
26.87%
register free of charge
CHF18.00
63.19%
register free of charge
CHF11.00
0.27%
register free of charge
|
|
A rating was issued by 18 analysts: 11 Analysts recommend Clariant to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Clariant stock has an average upside potential 2026 of
26.87%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion CHF | 4.38 | 4.14 |
15.79% | 5.42% | |
EBITDA Margin | 16.43% | 16.43% |
4.70% | 0.02% | |
Net Margin | 3.08% | 6.22% |
87.27% | 101.92% |
16 Analysts have issued a sales forecast Clariant 2024 . The average Clariant sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Clariant EBITDA forecast 2024. The average Clariant EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Clariant Analysts have issued a net profit forecast 2024. The average Clariant net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share CHF | 0.41 | 0.78 |
57.69% | 90.24% | |
P/E | 14.09 | |
EV/Sales | 1.31 |
11 Analysts have issued a Clariant forecast for earnings per share. The average Clariant <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Clariant stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG | Buy ➜ Buy | Unchanged | Dec 10 2024 |
BNP PARIBAS EXANE | Outperform ➜ Outperform | Unchanged | Nov 07 2024 |
RESEARCH PARTNERS AG | Buy ➜ Buy | Unchanged | Nov 04 2024 |
STIFEL EUROPE | Buy ➜ Buy | Unchanged | Nov 04 2024 |
BAADER HELVEA EQUITY RESEARCH | Buy ➜ Buy | Unchanged | Oct 28 2024 |
ODDO BHF | Buy ➜ Buy | Unchanged | Oct 28 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG: Buy ➜ Buy
|
Dec 10 2024 |
Unchanged
BNP PARIBAS EXANE: Outperform ➜ Outperform
|
Nov 07 2024 |
Unchanged
RESEARCH PARTNERS AG: Buy ➜ Buy
|
Nov 04 2024 |
Unchanged
STIFEL EUROPE: Buy ➜ Buy
|
Nov 04 2024 |
Unchanged
BAADER HELVEA EQUITY RESEARCH: Buy ➜ Buy
|
Oct 28 2024 |
Unchanged
ODDO BHF: Buy ➜ Buy
|
Oct 28 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.